Abstract

This paper introduces the concept of using acoustic sensing over the radial artery to extract cardiac parameters for continuous vital sign monitoring. It proposes a novel measurement principle that allows detection of the heart sounds together with the pulse wave, an attribute not possible with existing photoplethysmography (PPG)-based methods for monitoring at the wrist. The validity of the proposed principle is demonstrated using a new miniature, battery-operated wearable device to sense the acoustic signals and a novel algorithm to extract the heart rate from these signals. The algorithm utilizes the power spectral analysis of the acoustic pulse signal to detect the S1 sounds and additionally, the K-means method to remove motion artifacts for an accurate heartbeat detection. It has been validated on a dataset consisting of 12 subjects with a data length of 6 hours. The results demonstrate an accuracy of 98.78%, mean absolute error of 0.28 bpm, limits of agreement between −1.68 and 1.69 bpm, and a correlation coefficient of 0.998 with reference to a state-of-the-art PPG-based commercial device. The results in this proof of concept study demonstrate the potential of this new sensing modality to be used as an alternative, or to complement existing methods, for continuous monitoring of heart rate at the wrist.

Highlights

  • In recent years, the possibility of using wearable monitoring devices as medical devices has been the subject of significant interest worldwide

  • This paper shows for the first time how the heart rate (HR) can be obtained from the acoustic signal sensed with a wearable device attached to the wrist

  • The flow of the blood in the vessel expands the arterial diameter whereas a reduction in the arterial diameter is observed in the diastolic phase. These periodic changes in the arterial diameter are transferred through a thin layer of soft tissues and muscles to produce vibrations at the surface of the skin, which can be sensed to understand the dynamics of the heart and the blood vessel wall itself 2 1

Read more

Summary

Introduction

The possibility of using wearable monitoring devices as medical devices has been the subject of significant interest worldwide. This setup does not completely constrain the person’s motion, it does limit the daily activities if intended to be used for long term monitoring These limitations are addressed by some systems, both commercial and proposed in academic papers, that can be used to monitor ECG, with constraints, at different locations on the body. While wearable devices such as the Apple watch (Apple Inc., California, United States), KardiaBand (AliveCor Inc., California, United States), Salutron (Salutron Inc., California, United States), and BioWatch[5] provide spot measurements of ECG at the wrist, they are not suitable for a long-term cardiac monitoring. This conditions the size of the device, and the length of monitoring, as a result of the power demands of infrared LEDs

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call